Stocks and Investing Stocks and Investing
Tue, February 28, 2023

Vikram Purohit Maintained (AXSM) at Hold with Decreased Target to $85 on, Feb 28th, 2023


Published on 2024-10-28 01:57:17 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Decreased Target from $86 to $85 on, Feb 28th, 2023.

Vikram has made no other calls on AXSM in the last 4 months.



There are 7 other peers that have a rating on AXSM. Out of the 7 peers that are also analyzing AXSM, 1 agrees with Vikram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Amsellem of "Piper Sandler" Initiated at Hold and Held Target at $75 on, Thursday, January 5th, 2023


These are the ratings of the 6 analyists that currently disagree with Vikram


  • Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $210 on, Tuesday, February 14th, 2023
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Increased Target to $86 on, Monday, January 30th, 2023
  • Robert Hazlett of "BTIG" Maintained at Strong Buy with Increased Target to $98 on, Friday, December 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $85 on, Tuesday, November 29th, 2022
  • Esther Hong of "Loop Capital" Initiated at Strong Buy and Held Target at $95 on, Tuesday, November 1st, 2022
Contributing Sources